Skip to main content
. 2021 Nov 11;205(3):313–323. doi: 10.1164/rccm.202106-1404OC

Table 3.

AAT MM versus MZ Subjects with COPD in the ECLIPSE Study

Characteristic MM MZ P
n 1,684 100
Age, yr, mean (SD) 63.31 (7.15) 63.19 (6.40) 0.870
Sex, F, n (%) 587 (34.9) 32 (32.0) 0.635
Non-Hispanic White n (%) 1,647 (97.8) 96 (96.0) 0.409
Current smoker n (%) 610 (36.2) 27 (27.0) 0.078
Smoking pack-years, mean (SD) 48.35 (27.00) 47.21 (25.85) 0.682
Post-bronchodilator FEV1% predicted, mean (SD) 48.52 (15.54) 43.55 (16.48) 0.002
FEV1/FVC, mean (SD) 0.45 (0.11) 0.41 (0.11) <0.001
BODE index, mean (SD) 3.13 (2.08) 3.81 (2.42) 0.002
6-min-walk distance, feet, mean (SD) 1,219.71 (398.89) 1,194.72 (404.09) 0.553
SGRQ total score, mean (SD) 48.34 (18.37) 49.82 (18.80) 0.437
MMRC dyspnea score, mean (SD) 1.67 (1.05) 1.89 (1.16) 0.043
GOLD stage, n (%)      
 2 750 (44.5) 34 (34.0) 0.001
 3 720 (42.8) 41 (41.0)
 4 214 (12.7) 25 (25.0)
Percentage of emphysema, mean (SD) 17.03 (11.98) 22.67 (13.06) <0.001
Perc15, mean (SD) −949.93 (50.30) −970.79 (45.73) <0.001
Pi10, mean (SD) 4.40 (0.19) 4.38 (0.20) 0.325
Segmental wall area percentage, mean (SD) 65.77 (4.09) 64.91 (3.78) 0.048

Definition of abbreviations: AAT = alpha-1 antitrypsin; BODE = body mass index, airflow obstruction, dyspnea, and exercise; COPD = chronic obstructive pulmonary disease; CT = computed tomography; ECLIPSE = Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints; GOLD = Global Initiative for Chronic Obstructive Lung Disease; MM = PI MM genotype; MMRC = Modified Medical Research Council; MZ = PI MZ genotype; Perc15 = CT attenuation at the 15th percentile of the lung CT histogram; Pi10 = square root of the wall area of a theoretical airway with an internal perimeter of 10 mm; SGRQ = St. George’s Respiratory Questionnaire.

The percentage of emphysema is the percentage of lung voxels with CT attenuation ⩽−950 Hounsfield units at inspiratory CT.